Latest action: Referred to the House Committee on Energy and Commerce.
Referred to one or more standing committees for review, hearings, and possible markup.
Specific committees not parsed from action data.
The committee may hold hearings, amend the bill, or let it die without action.
Next: Reported
Full chamber floor — Speaker / Majority Leader controls scheduling
Updates biosecurity rules and encourages innovation in disease prevention.
The problem
Current biosecurity frameworks may not address emerging biological threats or support scientific advancement effectively.
The proposal
Modernizes biosecurity regulations and creates incentives for innovation in biological research safety.
The impact
Affects research institutions, scientists, public health agencies, and companies working with biological materials.
Modernizing biosecurity rules helps protect against new disease threats. Updated frameworks can catch emerging risks faster. This keeps public health systems better prepared.
Incentives for innovation encourage researchers to develop new safety technologies. This can lead to breakthroughs in disease prevention and treatment. Companies may invest more in biosecurity solutions.
Updated regulations create clearer standards for handling dangerous biological materials. Better oversight reduces risks of accidents or misuse. This protects both labs and surrounding communities.
Modernized systems can help identify and respond to biosecurity threats more quickly. Better communication between agencies improves coordination. This saves time in emergencies.
New regulations require research institutions and companies to upgrade facilities and processes. Smaller labs may struggle with expenses. This could slow down research at some organizations.
More rules and oversight can slow down research timelines. Scientists may spend more time on paperwork and compliance. This could delay important medical discoveries.
Different agencies must coordinate on new standards. Confusion about requirements could lead to inconsistent enforcement. Some facilities may struggle to understand expectations.
The bill provides no official summary, making it hard to assess exact requirements. Without specifics, stakeholders cannot prepare properly. This creates uncertainty for affected organizations.
Generated by AI from the bill text. Not a prediction and not legal or policy advice. The percentage is the model's own rating of each item — self-reported, and not a measure of how accurate it is.
Loading map…
Loading...
0 citizens have already voted
Free · No spam · See how your representatives voted
Be the first to weigh in
Your vote starts the conversation
How citizen engagement works
Citizens vote & comment
Public opinion data is aggregated and updated in real time.
Patterns become visible
Representatives can see constituent sentiment broken down by district.
Your voice on the record
Contact your rep directly — one constituent call can shift a staffer's priority list.
Research shows that constituent contacts — especially calls — are among the most effective ways to influence a legislator's position on active bills.
Individual contributions, grouped by employer · FEC
Where their individual donors work · 2026 cycle
Money from people who work there, not from the company. Not tied to this bill.
Itemized individual contributions via FEC, grouped by the employer each contributor self-reported. Companies and unions cannot contribute to federal candidates from their treasuries, so these totals are money from people who work at an employer — never from the organization itself. They are campaign contributions covering a full election cycle and are not connected to this bill.
Senate LDA lobbying disclosures
Couldn't load lobbying disclosures right now.